Should we treat the brain in glaucoma?
In: Canadian Journal of Ophthalmology, Jg. 42 (2007-06-01), Heft 3, S. 409-413
Online
academicJournal
Zugriff:
Abstract: The loss of retinal ganglion cells in glaucoma may lead to blindness, and current therapies are directed at reducing pressure within the eye. Most of the retinal ganglion cell axon lies outside the eye, and evidence from experimental primate and human glaucoma suggests that axon injury extends from the optic nerve to visual pathways in the brain. Neurodegenerative changes in the central visual system may contribute to the pathology of glaucomatous progression. Thus, intraocular pressure-lowering strategies combined with neuroprotective therapies to protect visual neurons in the retina and brain may help to preserve vision in patients with glaucoma. [Copyright &y& Elsevier]
Copyright of Canadian Journal of Ophthalmology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Should we treat the brain in glaucoma?
|
---|---|
Autor/in / Beteiligte Person: | Gupta, Neeru ; Yücel, Yeni H. |
Link: | |
Zeitschrift: | Canadian Journal of Ophthalmology, Jg. 42 (2007-06-01), Heft 3, S. 409-413 |
Veröffentlichung: | 2007 |
Medientyp: | academicJournal |
ISSN: | 0008-4182 (print) |
DOI: | 10.3129/i07-051 |
Schlagwort: |
|
Sonstiges: |
|